semaglutide 1ml Medications semaglutide 1ml 2.5 mg Semaglutide

Conclusions/interpretation Our data show that s.c

As far as we can tell, not a single trial assessed objective physical function: no grip strength, no walking speed, no real-world mobility

As one of the best skin brightening serums available, it targets dark spots, hyperpigmentation, and uneven skin tone

Kate Knibbs: OK

On-Treatment Monitoring IGF-1 should be rechecked at 8-12 weeks on sermorelin

Very important and practically oriented paper Nice overview of advantages and limitations A must read for anybody who treats these patients To view or add a comment, sign in GLP-1RAs Show Significant Liver and Metabolic Benefits in MASLD A new systematic review and meta-analysis of 32 randomized controlled trials reveals that GLP-1 receptor agonists (GLP-1RAs) significantly improve liver and metabolic outcomes in patients with Metabolic dysfunction-Associated Steatotic Liver Disease (MASLD), far outperforming DPP-4 inhibitors, which showed minimal effects beyond glycemic control